|Articles|September 2, 2020
Serialisation Regulations in the EU and USA
Author(s)PDA
This chapter, excerpted from the book Good Distribution Practice, provides background on serialization and how, despite initial investment of time and money, it will allow greater tracking of medicinal product through the drug supply chain and reduce the chance that falsified medicines end up in the hands of the public.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Why Context Matters in Validating Biomarker Assays for Bioanalysis
3
An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders
4
Targeted high resolution metabolite screening workflows
5
